Cargando…
IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942577/ https://www.ncbi.nlm.nih.gov/pubmed/35339305 http://dx.doi.org/10.1016/j.vaccine.2022.03.003 |
| _version_ | 1784673333330051072 |
|---|---|
| author | Abdel-Qader, Derar H. Hazza Alkhatatbeh, Issa Hayajneh, Wail Annab, Hassan Al Meslamani, Ahmad Z. Elmusa, Reem A. |
| author_facet | Abdel-Qader, Derar H. Hazza Alkhatatbeh, Issa Hayajneh, Wail Annab, Hassan Al Meslamani, Ahmad Z. Elmusa, Reem A. |
| author_sort | Abdel-Qader, Derar H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8942577 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89425772022-03-24 IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine Abdel-Qader, Derar H. Hazza Alkhatatbeh, Issa Hayajneh, Wail Annab, Hassan Al Meslamani, Ahmad Z. Elmusa, Reem A. Vaccine Letter to the Editor Elsevier Ltd. 2022-04-20 2022-03-24 /pmc/articles/PMC8942577/ /pubmed/35339305 http://dx.doi.org/10.1016/j.vaccine.2022.03.003 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Abdel-Qader, Derar H. Hazza Alkhatatbeh, Issa Hayajneh, Wail Annab, Hassan Al Meslamani, Ahmad Z. Elmusa, Reem A. IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine |
| title | IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine |
| title_full | IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine |
| title_fullStr | IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine |
| title_full_unstemmed | IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine |
| title_short | IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine |
| title_sort | iga nephropathy in a pediatric patient after receiving the first dose of pfizer-biontech covid-19 vaccine |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942577/ https://www.ncbi.nlm.nih.gov/pubmed/35339305 http://dx.doi.org/10.1016/j.vaccine.2022.03.003 |
| work_keys_str_mv | AT abdelqaderderarh iganephropathyinapediatricpatientafterreceivingthefirstdoseofpfizerbiontechcovid19vaccine AT hazzaalkhatatbehissa iganephropathyinapediatricpatientafterreceivingthefirstdoseofpfizerbiontechcovid19vaccine AT hayajnehwail iganephropathyinapediatricpatientafterreceivingthefirstdoseofpfizerbiontechcovid19vaccine AT annabhassan iganephropathyinapediatricpatientafterreceivingthefirstdoseofpfizerbiontechcovid19vaccine AT almeslamaniahmadz iganephropathyinapediatricpatientafterreceivingthefirstdoseofpfizerbiontechcovid19vaccine AT elmusareema iganephropathyinapediatricpatientafterreceivingthefirstdoseofpfizerbiontechcovid19vaccine |